| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 |
| filingDate |
2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a7115f85ea106f5cbe799a861dc2297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cb535ccd4b1f65175597b65a5eb2db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f97a4b7a60a1d2d75b6009429ef109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deebc27e78b2f587cb5cf0e8c43daa01 |
| publicationDate |
2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201109320-A |
| titleOfInvention |
Method for producing thiabenzoazulene propionic acid derivatives |
| abstract |
The present invention provides a method for manufacturing derivatives of thiabenzoazulene propionic acid, the derivatives of thiabenzoazulene propionic acid can be used as an effective ingredients for antihistamine agent. According to the manufacturing method of present invention could manufacture derivatives of thiabenzoazulene propionic acid which the second position of the thiabenzoazulene skeleton was substituted by propionic acid. The synthesized derivatives of thiabenzoazulene propionic acid possessing excellent histamine H1 receptor antagonistic action, and also exhibiting low intracerebral transitivity, can be used as an effective ingredients of pharmaceutical compositions such as antihistamine agent. |
| priorityDate |
2009-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |